Acesion Pharma
Business Services · Denmark · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ole Maaløes Vej 3, Copenhagen, Zealand, ...Phone Number
+45 44640876Website
www.acesionpharma.comRevenue
<$5 MillionIndustry
About Acesion Pharma
Acesion Pharma Org Chart
Is Acesion Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Acesion Pharma is spiking on competitors!
Funding: Get notified immidiatlly once Acesion Pharma has new funding data
Acesion Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Acesion Pharma had a recent Job posting/layoffs
Earning: See what the market has to say on Acesion Pharma recently announced quarterly report
Product Launch: Get notified when Acesion Pharma launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Acesion Pharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Acesion Pharma
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Acesion Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Acesion Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Acesion Pharma.
Acesion Pharma financials insights
Gather financial insights about Acesion Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$2.5M
Series A
$10M
Series B
$47M
Acesion Pharma Tech Stack
A closer look at the technologies used by Acesion Pharma
Most Recent Scoops
Acesion Pharma News & Media
Acesion Pharma announces Nature Medicine publication of clinical results in Atrial Fibrillation
AP30663 achieved proof of mechanism with first-in-class SK channel inhibition compound in atrial fibrillation – primary endpoint met: 99.9% probability of superiority over placebo AP31969, a novel compound being developed for sinus rhythm maintenance in atrial fibrillation, commences...Danish biotech raises €45M in Series B funding for its atrial fibrillation treatment
Copenhagen-based Acesion Pharma has successfully secured €45 million in Series B funding led by new investors Canaan and Alpha Wave, along with participationAcesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation
Financing co-led by new investors Canaan and Alpha Wave, and with participation by the Global BioAccess Fund and existing investor Novo Holdings COPENHAGEN, Denmark, Sept. 26, 2023 /PRNewswire/ -- Acesion Pharma ('Acesion' or 'the Company'), a biotech company pioneering first-in-class...
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Acesion Pharma
Acesion Pharma is dedicated to developing innovative therapies for the safe treatment of atrial fibrillation, the most common type of cardiac arrhythmia. The company is pioneering SK ion channel inhibition as a novel mechanism to enhance treatment efficacy and safety. Acesion Pharma is building a robust pipeline of best-in-class potential therapies... Read More